comparemela.com

Page 5 - Maureen Horton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vicore Pharma Holding AB: Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)

First clinical study with a digital therapy (DTx) in patients with IPF to address the psychological symptom burden in this diseaseFirst patient enrolled in US pilot phase leading up to the US

Vastra gotalands lanJessica shullMaureen hortonCarl johan dalsgaardJohns hopkins universityPrnewswire vicore pharma holdingCurebase incAlex therapeuticsProfessor maureen hortonJohns hopkinsDigital therapeuticsJohan dalsgaard

Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)

Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vastra gotalands lanJessica shullMaureen hortonCarl johan dalsgaardJohns hopkins universityPrnewswire vicore pharma holdingCurebase incVicore pharma holdingAlex therapeuticsProfessor maureen hortonJohns hopkinsDigital therapeuticsPharma holding

Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)

/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company, today announces the first patient enrolled in the pilot.

Vastra gotalands lanJessica shullMaureen hortonCarl johan dalsgaardJohns hopkins universityPrnewswire vicore pharma holdingCurebase incVicore pharma holdingAlex therapeuticsProfessor maureen hortonJohns hopkinsDigital therapeuticsJohan dalsgaardPharma holding

Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)

/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company, today announces the first patient enrolled in the pilot.

Vastra gotalands lanJessica shullMaureen hortonCarl johan dalsgaardJohns hopkins universityPrnewswire vicore pharma holdingCurebase incVicore pharma holdingAlex therapeuticsProfessor maureen hortonJohns hopkinsDigital therapeuticsJohan dalsgaardPharma holding

Vicore to host R&D Day

/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2.

United statesUnited kingdomVastra gotalands lanUniversity of southern californiaLos angelesCity ofVicore pharmaToby maherMaureen hortonGerry coghlanUniversity college londonJohns hopkins universityNational cardiac dublinNational pulmonary hypertension physicians associationRegional health authorityUniversity college dublin

vimarsana © 2020. All Rights Reserved.